These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 9845099

  • 1. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
    Kasai S, Nagasawa H, Kuwasaka H, Oshodani T, Nishioka A, Ogawa Y, Yoshida S, Inayama S, Inomata T, Hori H.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):799-802. PubMed ID: 9845099
    [Abstract] [Full Text] [Related]

  • 2. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
    Kasai S, Nagasawa H, Yamashita M, Masui M, Kuwasaka H, Oshodani T, Uto Y, Inomata T, Oka S, Inayama S, Hori H.
    Bioorg Med Chem; 2001 Feb 01; 9(2):453-64. PubMed ID: 11249137
    [Abstract] [Full Text] [Related]

  • 3. The immunopotentiation effects of the bifunctional radiosensitizer KIN-806 in comparison with its analogs KIN-804 and KIN-844.
    Inomata T, Ogawa Y, Nishioka A, Hamada N, Ito S, Kariya S, Yoshida S, Nagasawa H, Hori H, Inayama S.
    Oncol Rep; 1999 Feb 01; 6(6):1209-12. PubMed ID: 10523682
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
    Hori H, Jin CZ, Kiyono M, Kasai S, Shimamura M, Inayama S.
    Bioorg Med Chem; 1997 Mar 01; 5(3):591-9. PubMed ID: 9113337
    [Abstract] [Full Text] [Related]

  • 5. Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806.
    Inomata T, Ogawa Y, Itoh S, Kariya S, Hamada N, Nishioka A, Yoshida S, Nagasawa H, Hori H, Inayama S.
    Int J Mol Med; 1999 Sep 01; 4(3):257-60. PubMed ID: 10425275
    [Abstract] [Full Text] [Related]

  • 6. Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.
    Abou-Bedair FA, Hori H, Nagasawa H, Uto Y, Abu-Zeid M, Inayama S.
    Biol Pharm Bull; 2002 May 01; 25(5):591-6. PubMed ID: 12033498
    [Abstract] [Full Text] [Related]

  • 7. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T, Nakajima T, Onoyama Y, Murayama C, Mori T, Nagasawa H, Hori H, Inayama S.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):601-5. PubMed ID: 8005823
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers.
    Nakae T, Uto Y, Tanaka M, Shibata H, Nakata E, Tominaga M, Maezawa H, Hashimoto T, Kirk KL, Nagasawa H, Hori H.
    Bioorg Med Chem; 2008 Jan 15; 16(2):675-82. PubMed ID: 18029186
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 10. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N, Shibamoto Y, Sasai K, Shibata T, Murata R, Takagi T, Iwai H, Suzuki T, Abe M.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):119-27. PubMed ID: 7642409
    [Abstract] [Full Text] [Related]

  • 11. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T, Nakajima T, Onoyama Y, Nagasawa H, Hori H, Inayama S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May 25; 52(5):688-90. PubMed ID: 1508643
    [Abstract] [Full Text] [Related]

  • 12. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
    Tada T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan 25; 55(1):70-5. PubMed ID: 7899069
    [Abstract] [Full Text] [Related]

  • 13. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
    Oya N, Shibamoto Y, Shibata T, Murata R, Iwai H, Sugiyama T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):595-600. PubMed ID: 8005822
    [Abstract] [Full Text] [Related]

  • 14. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
    Jin CZ, Nagasawa H, Shimamura M, Uto Y, Inayama S, Takeuchi Y, Kirk KL, Hori H.
    Bioorg Med Chem; 2004 Sep 15; 12(18):4917-27. PubMed ID: 15336271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1991 Jun 15; 20(6):1249-54. PubMed ID: 1828462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
    Denny WA, Roberts PB, Anderson RF, Brown JM, Phil D, Wilson WR.
    Int J Radiat Oncol Biol Phys; 1992 Jun 15; 22(3):553-6. PubMed ID: 1735695
    [Abstract] [Full Text] [Related]

  • 19. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K, Shibamoto Y, Takahashi M, Abe M, Wang J, Zhou L, Nishimoto S, Kagiya T.
    Jpn J Cancer Res; 1989 Nov 15; 80(11):1113-8. PubMed ID: 2532634
    [Abstract] [Full Text] [Related]

  • 20. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep 15; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.